Diabetes mellitus and CVD are some of the leading causes of mortality and morbidity. Accumulating data indicate that a diet characterised by low-glycaemic index (GI) foods may improve the management of diabetes or lipid profiles. The objective of the present meta-analysis was to critically analyse the scientific evidence that low-GI diets have beneficial effects on carbohydrate and lipid metabolism compared with high-GI diets. We searched for randomised controlled trials with a crossover or parallel design published in English between 1981 and 2003, investigating the effect of low-GI v. high-GI diets on markers for carbohydrate and lipid metabolism. Unstandardised differences in mean values were examined using the random effects model. The main outcomes were fructosamine, glycated Hb (HbA 1c ), HDL-cholesterol, LDL-cholesterol, total cholesterol and triacylglycerol. Literature searches identified sixteen studies that met the strict inclusion criteria. Low-GI diets significantly reduced fructosamine by 2 0·1 (95 % CI 2 0·20, 0·00) mmol/l (P¼ 0·05), HbA 1c by 0·27 (95 % CI 2 0·5, 2 0·03) % (P¼0·03), total cholesterol by 2 0·33 (95 % CI 2 0·47, 2 0·18) mmol/l (P, 0·0001) and tended to reduce LDL-cholesterol in type 2 diabetic subjects by 2 0·15 (95 % CI 2 0·31, 2 0·00) mmol/l (P¼0·06) compared with high-GI diets. No changes were observed in HDL-cholesterol and triacylglycerol concentrations. No substantial heterogeneity was detected, suggesting that the effects of low-GI diets in these studies were uniform. Results of the present meta-analysis support the use of the GI as a scientifically based tool to enable selection of carbohydrate-containing foods to reduce total cholesterol and to improve overall metabolic control of diabetes.
Until recently carbohydrates in foods have been classified as 'simple' and 'complex', based on the degree of polymerisation of the carbohydrate. However, the effects of carbohydrate on health may be better described on the basis of their physiological effects (e.g. the ability to raise blood glucose levels), which depend on the type of constituent sugars (glucose, fructose and galactose), the physical form of the carbohydrate (particle size and degree of hydration), nature of the starch (amylose, amylopectin) and other food components (dietary fibre, fat, organic acids) (Augustin et al. 2002) . This classification is referred to as the glycaemic index (GI) of a food and was introduced by Jenkins et al. (1981) as a quantitative assessment of foods based on postprandial blood glucose response (Jenkins et al. 1981 (Jenkins et al. , 1984 , expressed as a percentage of the response to an equivalent carbohydrate portion of a reference food, such as white bread or glucose (Wolever et al. 1991) .
A high-GI food with an equivalent carbohydrate content as a low-GI food induces a larger area under the glucose curve over the postprandial period. As a consequence of the induced insulin response, intake of a high-GI food may result in lower blood glucose concentrations over the late (2 -3 h) postprandial period than that of a low-GI food . Reducing the rate of carbohydrate absorption by lowering the GI of the diet may have several health benefits, such as a reduced insulin demand, improved blood glucose control and reduced blood lipid concentrations (Augustin et al. 2002) . These are all factors that play important roles in preventing the onset of CVD and diabetes mellitus (DM).
Despite advances in the prevention and treatment in the second half of the 20th century (Liu, 2002) , CVD and DM are still some of the leading causes of mortality and morbidity. CVD is a multi-factorial disease, but its prevalence can also be attributed to a diet high in fat and low in fibre, with inadequate micronutrient intakes (Vorster et al. 1997) . Worldwide, the number of people with type 2 DM is expected to rise from 135 million in 1995 to 300 million in 2025 (King et al. 1998) . Insulin resistance and progressive pancreatic b-cell dysfunction are well-established fundamental steps in the pathogenesis of type 2 DM (Defronzo et al. 1992; Kahn 1994) . Accumulating metabolic and epidemiological data also indicate that impaired insulin action and compensatory hyperinsulinaemia often result in abnormal blood lipid patterns (elevations of triacylglycerol (TG) and low concentrations of HDL-cholesterol, as well as hypertension, which in turn increase the risk for CHD (Liu, 2002) ).
CVD and type 2 DM are common consequences of changing lifestyles (increasing sedentary lifestyles and increased energy density of diets). The conditions mentioned earlier are preventable through lifestyle modifications (Seidell, 2000) . But where does the GI fit in? According to Brand-Miller et al. (2002) , standard dietary advice to reduce fat intake while increasing carbohydrate intake generally increases the glycaemic effect of the diet. The type and amount of carbohydrate consumed influences postprandial glucose levels, and the interaction between the two may be synergistic. A diet high in refined carbohydrates and high-GI foods, such as white bread and potatoes, is rapidly digested and absorbed and results in a high glycaemic load and increased demand for insulin secretion (Holt et al. 1997) . When insulin resistance is prevalent and high-GI foods are consumed, postprandial hyperglycaemia and insulinaemia are magnified (Salmeron et al. 1997a,b) . On the other hand, low-GI, high-carbohydrate foods may maintain insulin sensitivity and increase the weight-loss potential of ad libitum low-fat diets (Ludwig, 2002) . Low-GI foods may also benefit weight control by promoting satiety and by promoting fat oxidation at the expense of carbohydrate oxidation. These qualities of low-GI foods can be attributed to the slower rates at which they are digested and absorbed and the corresponding effects on postprandial glycaemia and hyperinsulinaemia (Brand-Miller et al. 2002) .
However, there is no consensus on the importance of the GI to human health and nutrition (Ludwig & Eckel, 2002) . Many clinicians and researchers, especially in the USA, have questioned the relevance and practicality of the GI (Coulston & Reaven, 1997 This has led to a constructive debate internationally within the academic field, industry, health practitioners and regulatory authorities. It seems, therefore, imperative that a meta-analysis on the long-term physiological effects and health benefits of using the GI to construct diets should be done. A meta-analysis is the structured result of a literature review in which results from several independent but related or comparable studies are systematically and statistically combined or integrated in order to increase power and precision (Vorster et al. 2003) . We report the results of a meta-analysis to evaluate and integrate a number of studies conducted on the GI and its effects on health. The present meta-analysis summarises results and should further motivate and direct further research; it could form a firm, evidence-based platform for the use or not of the GI in planning diets.
Methods
Randomised controlled trials with a crossover or parallel design that were published between January 1981 and April 2003 were selected through a computer-assisted literature search. EbscoHost Web was used as a gateway to the databases Medline and Academic Search Premier. The Science Direct and PubMed (1981 -2003) databases were also used to expand our search. Medical subject headings (MeSH) such as 'glycaemic index' or 'glycemic index' combined with key words (metabolic control, cardiovascular disease, diabetes mellitus, obesity, weight, body mass index, blood lipids, cholesterol, high-density lipoprotein-cholesterol, low-density lipoprotein-cholesterol, total cholesterol, triacylglycerol, glycated (glycosylated) haemoglobin (hemoglobin), fructosamine, insulin, blood glucose) were used to search for papers. Low-GI diets were defined as those containing most carbohydrate from low-GI sources, such as peas, lentils, beans, pasta, barley, parboiled rice, oats and cereals, known to have a low GI. High-GI diets were those that contained potato, wheatmeal and white bread and high-GI varieties of breakfast cereals such as cornflakes and rice. Reference lists of all available published trials and relevant reviews were cross-checked manually to ensure that all applicable papers were included. Where data were incomplete, authors of the identified trials were contacted to supply comprehensive information. The search was restricted to human studies and only studies that were published in English were considered. Accepted interventions included a high-GI v. low-GI diet, investigating the effect of the diet on carbohydrate or lipid metabolism. The participants were patients with type 2 DM, type 1 DM or CVD, or healthy adults. Only studies with good quality methodology were considered. Quality criteria were adapted from the Effective Practice and Organization of Care Cochrane Group, and included methods of randomisation, blinded assessment of variables with regard to blood samples and determination of whether an intention-to-treat analysis was possible on all patients from the published data.
In addition, feeding periods had to be sufficiently long ($ 14 d) to allow the achievement of new steady-state concentrations of serum lipids and lipoproteins (Brussaard et al. 1982) as well as fructosamine (10 -14 d) and glycated Hb (HbA 1c ; 90 d) (Lindsey et al. 2002) , food intake had to be controlled (either advice given, key foods provided or all foods provided) and described (low-GI v. high-GI diets), the GI of the diet had to be indicated, the subject population had to be homogenous (at least for the main risk factor), and the inclusion and exclusion criteria for subjects had to be clearly defined.
Data extraction
Each potentially relevant study was assessed for inclusion independently by at least two reviewers. Two investigators (A. M. O. and C. S. V.), by means of an agreed standardised data collection form, independently extracted the relevant data. Co-investigators adjudicated areas of disagreement or uncertainty and resolved it by discussion. The k statistic for the agreement between the reviewers was 0·6 (a good agreement). Information about the outcome variables that was extracted for the randomised controlled trials included: authors, publication date, number of subjects, study design (crossover or parallel), duration of the study, wash-out period (if applicable), subject characteristics, the diet setting, reduction in GI, age, BMI and weight (maintenance or loss), provision of test meals, compliance, baseline and end values, mean change (end value -baseline value), and the P value and SD for both low-GI and high-GI groups. If SD were not presented, data on SEM or 95 % CI were extracted. Measured variables included in the meta-analysis were: risk markers of carbohydrate metabolism e.g. blood glucose, insulin, insulin resistance, glycated plasma protein (HbA 1c and fructosamine); risk markers for lipid metabolism e.g. TG, total cholesterol (TC), HDL-cholesterol, LDL-cholesterol and weight.
Data analysis
We used the Cochrane software package (Review manager 4.2; Cochrane, Copenhagen, Denmark) to process results. The mean difference over time for the high-GI diet was subtracted from the mean difference of the low-GI diet over time to get an overall difference between the two treatments. For each trial, we estimated the SD of the treatment effect for the outcome measures by using the SEM or paired differences (end values -baseline values) for low-GI and high-GI groups. If SD were not reported, they were estimated using the methods described by Follmann et al. (1992) . The net changes in TC, LDL-cholesterol, HDLcholesterol, TG and blood glucose are presented in mmol/l. Where variables were reported in mg/dl, converting factors were used (for TC, HDL-cholesterol and LDL-cholesterol, values in mg/dl were multiplied by 0·0259; for TG, values in mg/dl were multiplied by 0·0113 (Van Horn & Ernst, 2001) ). The variables blood glucose and insulin were not included in the meta-analysis, due to units that were not comparable, different time intervals of measurement, only insulin or glucose responses reported, incomplete and/or missing data, and only graphs and/or response curves given to report data. Unstandardised differences in mean values were examined using the random effects model. Weighted mean differences in mean values were also performed, because outcomes were measured in a standard way across studies.
Differences between the results of the trials were checked for heterogeneity by visual inspection of the graphs and by statistical test (x 2 ).
Results
The literature search yielded 413 references (titles and abstracts, original research and review papers). Of these, ninety-six original research papers were identified as possible studies to include in the meta-analysis. Two investigators examined the full-text publications, of which sixteen studies met the inclusion criteria. The main reason for exclusion was incomplete or missing data, response curves only for some of the variables (actual data not reported), and incompatible units. Details of the studies included in the meta-analysis are shown in Table 1 . There were two studies conducted in healthy subjects (Jenkins et al. 1987a; Bouche et al. 2002) , two in CHD (Frost et al. 1996 (Frost et al. , 1998 , nine in type 2 diabetic subjects Brand et al. 1991; Wolever et al. 1992a; Frost et al. 1994; Heilbronn et al. 2002; Jarvi et al. 1999; Luscombe et al. 1999; Tsihlias et al. 2000; Kabir et al. 2002) and three studies in type 1 diabetics (Collier et al. 1998; Lafrance et al. 1998; Gilbertson et al. 2001) . Studies were carried out under free-living conditions except for that of Frost et al. (1996) , who studied subjects who were hospitalised. Ten studies had a crossover and six a parallel design. A total of 396 subjects were studied (type 1 DM n 105, type 2 DM n 228, healthy n 17, CHD n 46). Intervention periods varied from 12 d to 6 months, wash-out periods from none to 7 weeks in crossover studies and a GI reduction of between 5 and 35 units was achieved. Studies that were excluded from the meta-analysis were those of Jenkins et al. (1985 Jenkins et al. ( , 1987b , Wolever et al. (1992b) , Calle-Pascual et al. (1988) , Fontvielle et al. (1988 Fontvielle et al. ( , 1992 , Brynes et al. (2003) , Gilbertson et al. (2003) and Wolever & Mehling (2003) , due to incomplete data for the purpose of the present meta-analysis. The reason for exclusion of such high profile studies was that baseline and end values of variables were not included, and therefore, SD could not be calculated. Twelve of the included studies assessed markers for carbohydrate metabolism, while fourteen studies assessed markers for lipid metabolism. Table 2 shows the nutrient composition of high-GI and low-GI intervention diets. The aim was to maintain the same proportions of macronutrients and fibre in both diets, but in some cases this was not achieved. Some high-GI diets were higher in fat and lower in fibre, complicating the interpretation of results.
Explanation of forest plots
The type of graphical display in the present meta-analysis used to report results is called a forest plot. The mean results of each computed study and the 95 % CI are reported. The midpoint of the square in the middle of the forest plot represents the effect size (the mean difference in the measure between low-GI and high-GI diets) and the horizontal line the 95 % CI of the individual studies. The size of the square relates to the weight each study Table 1 . Study design, number and characteristics of subjects, duration of study, wash-out period, settings and reduction in the glycaemic index* GI, glycaemic index; NR, not reported; TE, total energy. * For a summary of the studies, see Table 1 . † Low-GI diet contained less fat (25 v. 32 %) and more fibre (21 v. 14 g). ‡ Low-GI diet contained more fibre (26 g/4200 kJ (1000 kcal) v. 21 g/4200 kJ (1000 kcal)). § Low-GI diet contained more fibre (50 v. 23 g).
contributes to the meta-analysis (presented as a weighted mean difference). The weights are usually in inverse proportion to their variance, a method that gives more weight to larger studies and to studies with less variation in results. The diamond at the bottom of the graph gives a summary of the included studies statistics, which represents the mean difference (between low-GI and high-GI diets) and the 95 % CI (Vorster et al. 2003) . When the diamond does not touch the vertical line (the line of no effect) in the middle of the plot, it indicates that the overall effect is statistically significant. A random effects model was implemented to present the results. This model assumes that the studies used are a random sample from a hypothetical population of studies and consider both betweenstudy and within-study variation. Random effects models, however, are more conservative, generate wider 95 % CI and are less likely to show a significant treatment effect than the fixed effects model when significant heterogeneity exists between studies (Clarke & Oxman, 2001) . When homogeneity dominates (as in the present meta-analysis) both models give similar results.
Carbohydrate metabolism
Figs 1 and 2 represent the effects of low-GI v. high-GI diets on carbohydrate metabolism. For the present study, fructosamine and HbA 1c were investigated. No heterogeneity (Higgins et al. 2003) was detected for fructosamine (I 2 0 %; Fig. 1) . The random effects analysis demonstrated an overall statistically significant reduction in fructosamine in subjects receiving the low-GI diet compared with the high-GI diet (change 2 0·1 (95 % CI 2 0·20, 0·00) mmol/l; P¼ 0·05). However, when studies were subgrouped into DM and healthy subjects a non-significant improvement was observed in each group (DM, change 2 0·11 (95 % CI 2 0·25, 0·03) mmol/l, P¼ 0·12; healthy, change 2 0·09 (95 % CI 2 0·24, 0·06) mmol/l, P¼ 0·25). The GI reduction for the included studies was 24 (SD 9) units. Frost et al. (1994) and Wolever et al. (1992a) , who had the longest intervention periods, found the biggest change in mean fructosamine concentrations.
There was a statistically significant decrease in mean HbA 1c concentrations in subjects receiving the low-GI diet (change 2 0·27 (95 % CI 2 0·5, 2 0·03) %; P¼ 0·03) (Fig. 2) . No heterogeneity was detected (I 2 0 %). All the studies included, except that of Lafrance et al. (1998) , found an improvement in HbA 1c concentrations. The difference in GI between the low-GI and high-GI diets was 21 (SD 7) units. Brand et al. (1991) observed the biggest change with an intervention period of 12 weeks. All the included studies that measured HbA 1c in the present meta-analysis were performed on DM subjects.
Lipid metabolism
We investigated the effects of low-GI v. high-GI diets on markers for lipid metabolism such as HDL-cholesterol, LDL-cholesterol, TC and TG. Moderate heterogeneity (I 2 32·4 %; Higgins et al. 2003) was detected for Table 1 . GI, glycaemic index.
HDL-cholesterol. No heterogeneity (I 2 0 %) was observed for LDL-cholesterol, TC and TG.
Lowering the GI of the intervention diets by 22 (SD 9) units did not cause an overall significant change in mean HDL-cholesterol (change 2 0·03 (95 % CI 2 0·08, 0·02) mmol/l; P¼ 0·23) (Fig. 3) . From the forest plot it seems that neither high-GI nor low-GI diets had an effect on mean HDL-cholesterol concentrations in subjects with type 2 DM. Only Frost et al. (1996) investigated the effect of low-GI v. high-GI diets in subjects with CHD and found no significant difference. Jenkins et al. (1987a) and Bouche et al. (2002) found no statistically significant effect in healthy subjects.
Seven of the ten studies found an improvement in mean LDL-cholesterol concentrations on a low-GI diet (Fig. 4) . Overall, low-GI diets tended to decrease LDL-cholesterol concentrations; however, it was not statistically significant (change 2 0·15 (95 % CI 2 0·31, 0·00) mmol/l; P¼ 0·06). The GI of the diets was decreased by 21 (SD 10) units. In type 2 DM subjects, it seems that mean LDL-cholesterol concentrations were decreased to a greater extent than in subjects with CHD and healthy subjects. Larger decreases in LDL-cholesterol were reported for longer studies in well-controlled type 2 DM subjects (Brand et al. 1991; Frost et al. 1994 ) except for an unexpected non-significant increase in mean LDL-cholesterol concentrations after 6 months, as reported by Tsihlias et al. (2000) .
The random effects analysis demonstrated an overall statistically significant improvement in TC in subjects receiving low-GI diets compared with high-GI diets (change 2 0·33 (95 % CI 2 0·47, 2 0·18) mmol/l; P, 0·001). This improvement was achieved by lowering the GI of the intervention diet by 22 (SD 8) units. Larger decreases in TC concentrations were observed in patients with elevated TC baseline concentrations (. 5·2 mmol/l) Brand et al. 1991; Wolever et al. 1992a; Frost et al. 1994 Frost et al. , 1996 Jarvi et al. 1999; Luscombe et al. 1999; Bouche et al. 2002; Heilbronn et al. 2002; Kabir et al. 2002) . Two studies showed that mean TC concentrations of healthy subjects significantly improved on low-GI diets Bouche et al. 2002) , while the studies of Frost et al. (1996 Frost et al. ( , 1998 found no change in patients with CHD (Fig. 5) .
Only six of the thirteen studies showed an improvement in TG concentrations with a low-GI diet. Furthermore, the overall change was not statistically significant (change 0·03 (95 % CI 2 0·12, 0·17); P¼ 0·73). No improvement was observed by lowering the GI of the intervention diet by 20 (SD 9) units. When divided into subgroups no difference was found within type 2 DM, CHD or healthy subjects (Fig. 6) . No effect was observed when only subjects with elevated TG concentrations were included.
Discussion

Carbohydrate metabolism
Seven and eight of the sixteen randomised controlled trials measured fructosamine and HbA 1c respectively and indicated that low-GI diets overall decreased the markers Table 1 .
of blood glucose control statistically significantly. When dividing studies into subgroups of DM (type 1 and type 2) and healthy subjects, a non-significant decrease was reported for fructosamine in each group. However, the overall decrease was significant. HbA 1c was reported only in DM subjects and a statistically significant decrease was observed. Decreases in fructosamine and HbA 1c observed in the present meta-analysis are generally consistent with individual published reports. There was no heterogeneity among individual studies, suggesting that effects of low-GI diets on blood glucose control are uniform. Although studies included were of relatively short duration and small numbers of subjects participated, these results indicate that beneficial effects exist when using low-GI diets instead of high-GI diets in planning diets for DM subjects as well as healthy subjects. These findings are in accordance with meta-analyses conducted by BrandMiller (1994) , Brand-Miller et al. (2003) and Wolever (2003) , who looked mainly at the influence of the GI on markers for carbohydrate metabolism. However, BrandMiller et al. (2003) found a slightly larger reduction in glycated proteins, probably because of different statistical methods, a combination of the measurements of HbA 1c and fructosamine, and access to a larger number of studies. Our present meta-analysis is the first to investigate the effects of low-GI diets on markers for lipid as well as carbohydrate metabolism.
Fructosamine
Fructosamine is measured as a short-term (2 weeks) index of glycaemic control. Glycated albumin is the main constituent of fructosamine and has a half-life of only 12 d, explaining the usefulness of fructosamine as a short-term marker (Kumar & Clarke, 1998) . The studies of Jenkins et al. (1987a Jenkins et al. ( , 1988 contributed the most weight to the meta-analysis, irrespective of the fact that only six and eight subjects participated in the studies and intervention periods were only 2 weeks long. This could be attributed to the small CI of the studies. Frost et al. (1994) and Wolever et al. (1992a) found the biggest improvement in mean fructosamine concentrations. These two studies had the longest intervention periods. Although fructosamine is a shorter-term marker for blood glucose control than HbA 1c , it seems that the longer low-GI diets are followed, the larger the decreases in fructosamine concentrations that are observed. According to Jones et al. (1983) , maximum changes in fructosamine take 4-6 weeks to occur. More profound decreases were documented in DM subjects than in healthy subjects. Results would probably be more representative if all available studies conducted on fructosamine and the GI could be included, but due to a lack of complete data (mean values and SD of baseline and end values) this was not possible. However, the combined meta-analysis suggests that low-GI diets will reduce Table 1. mean fructosamine concentrations by 0·1 mmol/l above that seen with high-GI diets over a period of 4·6 (SD 3) weeks. GI reductions of 24 (SD 9) units were achieved.
Glycated Hb
HbA 1c is a longer-term marker for carbohydrate metabolism than fructosamine. This test provides an index of the average blood glucose concentration over the half-life of the Hb molecule (approximately 6 weeks) (Kumar & Clarke, 1998) . Studies that lasted longer than 4 weeks showed greater improvements in HbA 1c concentrations than in shorter studies. However, the study of Tsihlias et al. (2000) lasted 6 months, but no improvement in HbA 1c concentration was seen. This may be attributed to the fact that only a small GI reduction of 11 units was observed, the GI of only one meal (breakfast) was lowered and the possibility of poorer compliance with longer studies exists. Brand et al. (1991) attained the biggest reduction over a period of 12 weeks, although the GI reduction was only 13 units. They studied well-controlled DM subjects and reduced the GI of the whole diet and not just a single meal. Nonetheless, from these results one may conclude that low-GI diets beneficially influenced long-term glycaemic control. A significant reduction of 0·27 % in HbA 1c concentrations may be expected over a period of 8 (SD 8) weeks with a GI reduction of 21 (SD 7) units. In addition, more than one type of low-GI food may need to be incorporated into the diet to achieve measurable long-term improvements in glycaemic control. Differences in fructosamine and HbA 1c might be confounded by differences in energy intake or weight loss. In most studies body weight, energy intake, fat, protein and carbohydrate and fibre intake were held constant.
Poor blood glucose control has been associated with a greater incidence of long-term macrovascular complications in both type 1 and type 2 DM patients (Balkau et al. 1998; UK Prospective Diabetes Study Group, 1998; Couthinho et al. 1999; Stratton et al. 2000) . The UK Prospective Diabetes Study Group found that each 1 % reduction in mean HbA 1c concentration was associated with reductions in risk of 21 % for deaths related to diabetes, 14 % for myocardial infarction and 37 % for microvascular complications. It is not clear precisely how low-GI diets improve the markers of carbohydrate metabolism and prevent the onset of type 2 DM. Several mechanisms have been proposed. Briefly, high-GI diets have been associated with high postprandial blood glucose concentrations and increased insulin demands (Ludwig, 2002; Willet et al. 2002) . Primary hyperinsulinaemia may cause insulin resistance, which reduces insulin sensitivity. In addition, habitual consumption of high-GI meals in the long-term initiates a cycle of hyperinsulinaemia and insulin resistance, leading to a loss of pancreatic b-cell function (Ludwig, 2002) ; this can result in glucose intolerance and an irreversible state of DM (Willet et al. 2002) . Hyperglycaemia also causes deleterious effects on counterregulatory hormone secretion, increased late postprandial serum NEFA concentrations (Ludwig, 2002) and leads to the occurrence of oxidative stress (Augustin et al. 2002) . Low-GI diets, on the other hand, tend to delay glucose absorption, thereby resulting in reduced peak insulin concentrations and overall insulin demand (Augustin et al. 2002) .
Considering epidemiological evidence, the cross-sectional EURODIAB Complications Study (n 2054) reported that the lower GI diet of European outpatients with type 1 DM was associated with significantly lower HbA 1c concentrations. Compared with the highest GI quartile, adjusted HbA 1c in the lowest quartile was 11 % lower in patients from southern European centres and 6 % lower in patients from the rest of the European centres (Buyken et al. 2001) . Furthermore, the Framingham Heart Study showed a strong positive association between prevalence of CHD and increased HbA 1c concentrations, suggesting the importance of hyperglycaemia in the development of CHD (Singer et al. 1992) .
Lipid metabolism
The present meta-analysis pooled the results of fourteen randomised controlled trials studying low-GI v. high-GI diets and their effects on markers for lipid metabolism.
In the studies reviewed, low-GI diets caused a statistically significant improvement in TC concentrations, while non-significant improvements were observed in LDLcholesterol. No significant change was found in TG and HDL-cholesterol with low-GI diets. The unchanged HDL-cholesterol concentrations were somewhat unexpected, since cross-sectional studies, such as the Survey of British Adults (1986 -1987 Frost et al. 1999 ) and the Third National Health and Nutrition Examination Survey Ford & Liu, 2001) , found an increase in HDL-cholesterol concentrations with low-GI diets in the long term. It should also be noted that differences in lipids might be confounded by differences in energy intake or weight loss. In most studies body weight, energy intake, fat, protein and carbohydrate and fibre intake were held constant.
HDL-cholesterol
A possible explanation for the unchanged HDL-cholesterol concentrations is the length of studies. Intervention periods differed from 2 weeks to 6 months. Although the study of Tsihlias et al. (2000) was the longest (6 months), they also observed no effect. However, in that study the GI of only one meal (breakfast) was lowered.
A low HDL-cholesterol concentration is a strong independent predictor of CHD and has several causes, many Table 1. of which are associated with insulin resistance, elevated TG, overweight and obesity, physical inactivity and type 2 DM (Adult Treatment Panel III, 2001 ). While we found no significant change for HDL-cholesterol in randomised controlled trials, some cross-sectional epidemiological studies found improvements. In the Third National Health and Nutrition Examination Survey (1988 -1994) an inverse relationship was found between the GI and HDL-cholesterol concentrations (n 13 907). Ford & Liu (2001) reported a statistically significant change in HDLcholesterol concentrations of 2 0·06 mmol/l per 15 unit increase in the GI, after adjusting for covariates such as gender, BMI, smoking status, alcohol intake, physical activity, energy intake derived from fat and carbohydrate, etc. HDL-cholesterol concentrations for the lowest and the highest GI quintiles were 1·36 and 1·28 mmol/l respectively. Frost et al. (1999) , who reported data from the Survey of British Adults (1986 Adults ( -1987 , found a significant negative relationship between serum HDL-cholesterol concentration and the GI of the diet for both men (P¼ 0·02) and women (P, 0·0001). For women the improvement in HDL-cholesterol concentrations between the lowest and the highest quintile of the GI was 0·25 mmol/l, representing a possible 29 % reduction in CHD morbidity. In men the potential decrease in CHD morbidity was found to be 7 %, reflecting a 0·09 mmol/l difference in HDL-cholesterol concentration between the lowest and the highest quintiles of the GI.
In the EURODIAB Complications Study, higher HDLcholesterol concentrations were observed in patients from the northern, eastern and western European centres who consumed low-GI diets. The observed relationships of the dietary GI with HDL-cholesterol concentrations were independent of dietary fibre intake (Buyken et al. 2001) . However, in the Zutphen Elderly Study, conducted on elderly male subjects, no associations were found between the GI and HDL-cholesterol concentrations. These differences in findings between the epidemiological studies could be attributed to the age and gender differences between study populations (Van Dam et al. 2000) .
Although no overall improvement in HDL-cholesterol was found in the present meta-analysis such an improvement was expected, because low-GI foods are associated with reduced hepatic gluconeogenesis, suppression of NEFA release and therefore increases in the HDL-cholesterol fraction (Wolever 2000; Rizkalla et al. 2002) . Furthermore, Augustin et al. (2002) suggested that lower postprandial blood glucose concentrations after low-GI meals might reduce acute and chronic inflammatory responses and raise HDL-cholesterol concentrations when compared with high-GI diets. These discrepancies in results between randomised controlled trials and Table 1 .
epidemiological studies could be due to the difference in the length of intervention periods. Therefore, long-term intervention studies are needed to assess the effects of low-GI diets on HDL-cholesterol concentrations (Frost et al. 1999) . et al. (1994) and Wolever et al. (1992a) reported the most profound improvement in LDL-cholesterol concentrations. In the study of Frost et al. (1994) the GI of the whole diet was lowered by only 5 units over a 12-week period, while Wolever et al. (1992a) reduced the GI of the diet by 28 units over a 6-week period. Jarvi et al. (1999) and Brand et al. (1991) also found notable decreases in LDL-cholesterol concentrations after periods of 24 d and 12 weeks respectively, and with GI reductions of 19 and 13 units. Nutrient compositions within the studies of Wolever et al. (1992a) , Jarvi et al. (1999) and Brand et al. (1991) , as well as between the high-GI and low-GI groups, remained the same. Therefore, the tendency for LDL-cholesterol to decrease can be attributed to the effect of the low-GI diets. The most substantial effects were observed in type 2 DM subjects. The GI reduction of only 5 units in the study of Frost et al. (1994) is small. They concluded that the effect of the change in LDL-cholesterol could be caused by changes in dietary constituents due to a significant drop in fat intake and a significant increase in fibre intake in the group that followed the low-GI diet (Frost et al. 1994) . The low-GI group also had higher baseline LDL-cholesterol concentrations than the control group.
LDL-cholesterol
Frost
Not all available studies conducted on the GI and LDLcholesterol could be included. The randomised controlled trials of Jenkins et al. (1985 Jenkins et al. ( , 1987b showed promising results on low-GI diets and LDL-cholesterol, but did not report mean values and SD for the change. Both these studies found significant improvements in LDL-cholesterol concentrations with low-GI diets. However, epidemiological studies, such as the Zutphen Elderly Study (Van Dam et al. 2000) and the EURODIAB Complications Study (Buyken et al. 2001) , failed to prove a relationship between LDL-cholesterol concentrations and low-GI diets.
When comparing corresponding studies that measured markers for carbohydrate metabolism and LDL-cholesterol (Brand et al. 1991; Jarvi et al. 1999; Heilbronn et al. 2002) , improvements in LDL-cholesterol concentrations were observed where decreases in fructosamine and HbA 1c were perceived. But how can low-GI diets contribute to lower LDL-cholesterol concentrations? A possible mechanism may be that insulin resistance may occur with consumption of a high-GI meal because of the direct effects of hyperglycaemia (Ludwig, 2002) . Insulin resistance impairs normal suppression of NEFA release from adipose tissue in the postprandial state (Granberry & Fonseca, 1999) . According to Timar et al. (2000) , increased NEFA released from abdominal adipose tissue, delivered to the liver, offers an efficient substrate for enhanced synthesis of TG and VLDL-cholesterol, resulting in elevated cholesterol concentrations. Furthermore, with the prevalence of insulin resistance as seen in type 2 DM subjects, LDL-receptor activity is reduced, resulting in less LDL-cholesterol removal from the blood, thereby contributing to higher LDL-cholesterol concentrations (Garg, 1996) . Barakat et al. (1996) explained that reduced receptor activity may be attributed to glycation of the LDL-particle in the presence of hyperglycaemia. Glycated LDL-cholesterol cannot bind as efficiently as non-glycated LDL because of impairment in the binding of the LDL particles to LDL-receptors; therefore, glycated LDL particles will remain in the circulation longer.
From these results it seems that low-GI diets have favourable effects on LDL-cholesterol concentrations in type 2 DM subjects. A reduction of 0·15 mmol/l in LDLcholesterol concentrations with low-GI diets can be expected over a period of 10 (SD 7) weeks with a reduction of 28 (SD 8) units in the GI of the diet. It is also recommended that more long-term studies should be performed to investigate the relationship between low-GI diets and LDL-cholesterol.
Total cholesterol
There was no substantial heterogeneity (Higgins et al. 2003) among included studies, suggesting that the effects of low-GI diets on TC are uniform. Considering type 2 DM subjects, all the included studies, except that of Tsihlias et al. (2000) , reported elevated (. 5·2 mmol/l) baseline TC concentrations. After receiving low-GI intervention diets all the studies showed an improvement in TC to some extent. Only the study of Tsihlias et al. (2000) found a slight increase in TC with low-GI diets. No significant improvements were observed in the two studies conducted on CHD patients, while a significant reduction was observed in the two studies performed on healthy subjects. From these findings it can be concluded that by lowering the GI by 19 (SD 8) units over 8 (SD 6) weeks, a significant decrease of 0·3 mmol/l can be expected in TC concentrations of type 2 DM subjects. However, epidemiological evidence from the EURODIAB Complications Study (Buyken et al. 2001) , the Zutphen Elderly Study (Van Dam et al. 2000) and the Survey of British Adults (Frost et al. 1999) failed to show any inverse relationship between low-GI diets and TC.
The mechanisms by which low-GI diets may reduce TC concentrations remain unclear. Speculatively, these mechanisms involve: lower insulin-stimulated 2-hydroxy-2-methylglutaryl-CoA reductase activity as a result of a reduced rate of carbohydrate absorption; impaired bile acid and cholesterol reabsorption from the ileum due to the high fibre content of low-GI foods; inhibition of hepatic cholesterol synthesis by SCFA, such as propionate (Augustin et al. 2002) .
Triacylglycerol
We could not find notable effects on TG concentrations with low-GI or high-GI diets. It also seems that the type of subjects did not influence results. Only Wolever et al. (1992a) and Luscombe et al. (1999) found decreases with low-GI diets. In both studies baseline TG concentrations were elevated (. 1·69 mmol/l; Kratz & Lewandrowski, 1998) . No relationship was found between low-GI diets and TG when investigating epidemiological data (Van Dam et al. 2000; Buyken et al. 2001) .
Contrary to the general belief, an inverse relationship between low-GI diets and TG was found. According to Wolever et al. (1992b) , insulin regulates both cholesterol and TG synthesis. One would therefore expect an improvement in TG concentrations, because markers for carbohydrate metabolism (HbA 1c ) in the present metaanalysis significantly improved. Furthermore, it appears obvious that improved blood glucose control would reduce insulin resistance accompanied by an improvement in TG concentrations. Nevertheless, intra-individual biological variation in TG concentrations has been well documented (Nazir et al. 1999; Castro Cabezas et al. 2001) . According to Nazir et al. (1999) and Castro Cabezas et al. (2001) , several factors contribute to the variation of TG, such as intervention diet (amount of fat and carbohydrate), exercise, alcohol consumption, diurnal and seasonal variation and smoking, and could possibly explain the lack of effects on TG concentrations.
Conclusion
From the present meta-analysis on randomised controlled trials, it is clear that implementing the GI concept in choosing carbohydrate-containing foods beneficially influenced carbohydrate and lipid metabolism. These results are supported by experimental evidence from the last 20 years.
The low-GI diets significantly improved blood glucose control in type 2 DM subjects. These findings were in accordance with other meta-analyses conducted on markers of carbohydrate metabolism (Brand-Miller, 1994; BrandMiller et al. 2003; Wolever, 2003) . Regarding lipid metabolism, a significant improvement in LDL-cholesterol and TC was observed for type 2 DM subjects, while TG and HDLcholesterol concentrations were not influenced. Only two randomised controlled trials were performed: CHD patients and healthy subjects. No notable effects of a low-GI diet on lipid and carbohydrate metabolism were observed in these patients. It is therefore difficult to draw a final conclusion. More studies should therefore be conducted in non-DM subjects to investigate the effect of low-GI diets on HDL-cholesterol, LDL-cholesterol and TC concentrations. Furthermore, many of the studies included in the present meta-analysis involved only small numbers of subjects and were of short duration: it is recommended that more long-term studies should be conducted.
Nonetheless, results from the present meta-analysis support the use of the GI as a scientifically based tool in selecting carbohydrate-containing foods. It appears that a low-GI diet has independent effects contributing to a healthy diet. When incorporating these benefits with other dietary interventions such as a high-fibre and lowsaturated-fat diet, and adequate amounts of micronutrients, the influence of low-GI diets will probably be magnified and clinically significant effects may be expected.
